Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3338270 | Indian Journal of Transplantation | 2014 | 4 Pages |
Abstract
We report a case of a renal transplant recipient treated with tacrolimus, who developed Thrombotic microangiopathy (TMA). TMA is a well-documented, severe and acute adverse effect of tacrolimus that occurs after solid-organ transplant. He was managed with complete withdrawal of tacrolimus, increasing the dose of mycophenolate mofetil and plasmapharesis with fresh-frozen plasma as replacement fluid. This was resulted in normalization of renal functions. The remission was sustained during follow-up of 12 months.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Dharmendra Prasad, Dhananjai Agarwal, Vinay Malhotra, Mohit Mathur, Rajesh Garsa, Kunal Gandhi, Pankaj Beniwal,